arrow
E

Emma Calabrese

policlinico universitario tor vergata
H指数:46
被引数:8,190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology

免疫介导性疾病中的创新与可持续性:意大利胃肠病学、皮肤病学和风湿病学多学科共识

2026-06-030
OAAI
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care (vol 25, 104068, 2026)

炎症性肠病中的动态特征分析:个性化护理的宣言(卷 25,104068,2026)

2026-06-010
OAAI
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn’s disease: A real- world latium net study

维多珠单抗用于克罗恩病术后复发的预防和治疗:一项真实世界Latium网络研究

2026-05-300
OAAI
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study

炎症性肠病患者中的癌症病史患者:免疫调节剂在多中心研究中的安全性

2025-10-110
OAAI
Clinical outcome after entero-enteric anastomosis for Crohn's disease: a case-control study

克罗恩病肠-肠吻合术后的临床结局:一项病例对照研究

2025-09-010
OAAI
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies - Insights from the IUS IG-IBD (Italian Group for the Study of Inflammatory Bowel Disease) Master Program
2025-01-220
PRE
Effectiveness and safety of Risankizumab in Crohn's disease patients from a large Italian cohort: preliminary results from the RESOLVE IgIBD study
2025-01-220
PRE
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey

IBD患者的过渡护理: 儿科和成人胃肠病学家的观点。来自全国调查的结果

2024-05-010
PRE
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF,Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
2022-07-2731
OA
Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study
2022-04-0150
OAAI